In Silico Insights towards the Identification of SARS-CoV-2 NSP13 Helicase Druggable Pockets

Biomolecules. 2022 Mar 22;12(4):482. doi: 10.3390/biom12040482.

Abstract

The merging of distinct computational approaches has become a powerful strategy for discovering new biologically active compounds. By using molecular modeling, significant efforts have recently resulted in the development of new molecules, demonstrating high efficiency in reducing the replication of severe acute respiratory coronavirus 2 (SARS-CoV-2), the agent responsible for the COVID-19 pandemic. We have focused our interest on non-structural protein Nsp13 (NTPase/helicase), as a crucial protein, embedded in the replication-transcription complex (RTC), that controls the virus life cycle. To assist in the identification of the most druggable surfaces of Nsps13, we applied a combination of four computational tools: FTMap, SiteMap, Fpocket and LigandScout. These software packages explored the binding sites for different three-dimensional structures of RTC complexes (PDB codes: 6XEZ, 7CXM, 7CXN), thus, detecting several hot spots, that were clustered to obtain ensemble consensus sites, through a combination of four different approaches. The comparison of data provided new insights about putative druggable sites that might be employed for further docking simulations on druggable surfaces of Nsps13, in a scenario of repurposing drugs.

Keywords: COVID-19; FTMap; Fpocket; LigandScout software packages; Nsp13; SiteMap; binding site prediction; protein structure.

MeSH terms

  • Antiviral Agents* / chemistry
  • Binding Sites
  • COVID-19
  • Humans
  • Pandemics
  • RNA Helicases* / antagonists & inhibitors
  • SARS-CoV-2* / drug effects
  • Viral Nonstructural Proteins* / antagonists & inhibitors

Substances

  • Antiviral Agents
  • Viral Nonstructural Proteins
  • RNA Helicases